Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Nof Corporation patents


Recent patent applications related to Nof Corporation. Nof Corporation is listed as an Agent/Assignee. Note: Nof Corporation may have other listings under different names/spellings. We're not affiliated with Nof Corporation, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "N" | Nof Corporation-related inventors


Nof Corporation

. . ... Nof Corporation

Matrix-assisted laser desorption mass spectrometry of high molecular weight polyoxyethylene derivative

A matrix-assisted laser desorption (maldi) mass spectrometry in which a mixture comprising a polyethylene glycol derivative having a molecular weight of 40,000 or more and a matrix is irradiated with laser beam to vaporize the polyethylene glycol derivative together with the matrix, thereby measuring a molecular weight of the polyethylene glycol derivative, wherein as the matrix, a low polar matrix having a 1-octanol/water partition coefficient (log pow) of 4.1 to 4.8 is used. Also disclosed is a matrix for use in the matrix-assisted laser desorption (maldi) mass spectrometry.. ... Nof Corporation

Biodegradable polyethylene glycol derivative having cyclic benzylidene acetal linker

A biodegradable polyethylene glycol derivative in which a polyethylene glycol chain is linked by an acetal linker capable of accurately controlling the hydrolysis rate under different ph environments in the living body, and whose division rate into a polyethylene glycol chain of low molecular weight in the living body can be accurately controlled. The biodegradable polyethylene glycol derivative is represented by formula (1) or formula (2) as described.. ... Nof Corporation

Nof Corporation

. . ... Nof Corporation

Polymer and crosslinked body thereof

Provided are a copolymer having enough biocompatibility to be used in a medical material application, and a method of forming a crosslinked body, which involves modifying a substrate surface with the copolymer so that the surface may be biocompatible. More specifically, a protein adsorption-suppressing effect and a cell adhesion-suppressing effect, which are features of a phosphorylcholine group, are imparted to the substrate surface. ... Nof Corporation

Eyedrops

Provided is an ophthalmic solution for treatment or prevention of lid wiper epitheliopathy, which is capable of imparting sufficient lubricity to a corneal surface or a soft contact lens surface. It has been found that the above-mentioned object can be achieved by an ophthalmic solution containing, at a specific ratio, a copolymer having a structure having three kinds of different constituent units at a specific ratio.. ... Nof Corporation

Method for suppressing protein adsorption

Provided is a novel method of suppressing non-specific protein adsorption. The above-mentioned object can be achieved by treating a solid phase with a solid phase-treating liquid containing a phosphorylcholine group-containing polymer as a main component, and treating a specimen with a specimen-treating liquid containing, as a main component, a polymer having a phosphorylcholine group, a hydroxy group, and a hydrophobic group, followed by addition of the treated specimen to the treated solid phase.. ... Nof Corporation

Method for producing container for forming embryoid body

An object is to provide a method of manufacturing a vessel for embryoid body formation excellent in formability of an embryoid body and suitable for optical observation.. . ... Nof Corporation

Nof Corporation

. . ... Nof Corporation

Ethylene vinyl acetate copolymer resin composition, graft copolymer, thermoplastic resin composition, and molded resin article

An ethylene-vinyl acetate copolymer resin composition includes: an (a) ethylene-vinyl acetate copolymer; a (b) vinyl copolymer; and a (c) organic peroxide. The (b) vinyl copolymer and the (c) organic peroxide are impregnated in the (a) ethylene-vinyl acetate copolymer. ... Nof Corporation

Surface physical property modifier composition, thermoplastic resin composition containing same, and resin molded article therefrom

A surface physical property modifier composition includes (a) a wax, (b) a vinyl (co)polymer, and (c) an aliphatic hydrocarbon having a carbon number of 5 to 14. Component (a) is set to be at least one selected from the group consisting of (a1) paraffin wax, (a2) microcrystalline wax, (a3) fischer-tropsch wax, and (a4) polyethylene wax, and component (b) is produced from at least one of (b1) a (meth)acrylonitrile, (b2) a (meth)acrylic acid having a carbon number of 1 to 4, (b3) a hydroxyethyl (meth)acrylate or hydroxypropyl (meth)acrylate, (b4) styrene, and (b5) predetermined (meth)acrylic acid alkyl esters. ... Nof Corporation

Antibody-drug conjugate having cyclic benzylidene acetal linker

An antibody-drug conjugate having a cyclic benzylidene acetal linker represented by formula (1) or formula (2), wherein y is an antibody; d is a drug; r1 and r6 are each independently a hydrogen atom or a hydrocarbon group; r2, r3, r4 and r5 are each independently an electron-withdrawing or electron-donating substituent or a hydrogen atom; s is 1 or 2, t is 0 or 1, and s+t is 1 or 2; w is an integer of 1 to 20; and z1 and z2 are each independently a selected divalent spacer:. . ... Nof Corporation

Nof Corporation

. . ... Nof Corporation

Oral composition for alleviation of dentin hypersensitivity

An oral composition for reducing dentinal hypersensitivity according to the present invention comprises a phosphorylcholine-containing polymer as an active ingredient. A general consumer can use the oral composition routinely in various forms. ... Nof Corporation

09/28/17 / #a method for producing a cationic lipid, wherein a cationic lipid represented by formula (1) is mixed with a tetraalkylammonium salt having x− in an organic solvent, and a filtrate obtained by separating a tetraalkylammonium iodide deposited by filtration is concentrated to deposit a tetraalkylammonium iodide, thereby obtaining a cationic lipid represented by formula (2):

Nof Corporation

. . ... Nof Corporation

09/14/17 / #a protein adsorption inhibitor includes a compound of formula (1) as an active ingredient. the protein adsorption inhibitor is capable of highly inhibiting non-specific adsorption of a protein such as an antibody or an enzyme to a surface of a base body such as an immune reaction vessel or an assay instrument. also provided is a coating layer-formed base body having a coating layer containing the protein adsorption inhibitor on the base body. the coating layer-formed base body has an excellent protein adsorption-inhibiting function. a method for inhibiting the adsorption of the protein to the base body is provided. the method includes forming the coating layer containing the protein adsorption inhibitor on the surface of the base body:

Nof Corporation

. . ... Nof Corporation

08/24/17 / #[object] to provide a phosphorylcholine group-containing compound capable of producing a phosphorylcholine complex, and the phosphorylcholine complex, the phosphorylcholine complex being easily manufactured and suitable for use as a phosphorylcholine antigen.

Nof Corporation

. . ... Nof Corporation

08/10/17 / #there is provided a protein stabilizer containing a compound represented by formula (1) as an active ingredient. the protein stabilizer is capable of stabilizing a protein in a solution state for a long period of time without affecting an assay system, the protein being not limited to enzymes, labeling substances such as fluorescent substances and chemiluminescent substances, and assay target substances. there is also provided a protein stabilization method containing making the protein coexist with the compound represented by formula (1) in a water-containing solution.

Nof Corporation

. . ... Nof Corporation

05/18/17 / #the present invention provides a polymer compound that can be expected to inhibit activation of a coagulation system, a complement system or a platelet system when brought into contact with in vivo tissue and/or blood since the compound is capable of containing intermediate water, and a composition and a device using the same. this problem is solved by a polymer compound containing a repeating unit represented by general formula (a), and used in contact with in vivo tissue and/or blood, in which in a process in which the polymer compound caused to contain water in a prescribed water content is cooled to −100° c. and thereafter heated at a temperature rise rate of 5.0° c./min, a temperature region where exothermicity occurs is present in the range of −80° c. or more and −25° c. or less, and a temperature region where endothermicity occurs is present in the range of −25° c. or more and lower than 0° c.:

Nof Corporation

. . ... Nof Corporation

04/20/17 / #a hydrophilic polymer derivative having a cyclic benzylidene acetal linker represented by the following formula (1):

Nof Corporation

. . ... Nof Corporation








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Nof Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Nof Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###